This study aims to find the best dose of BI 907828 (brigimadlin) in patients with different types of advanced cancer (solid tumors)

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511503-41-00

Acronym

1403-0001

Enrollment

112

Registered

2024-09-26

Start date

2021-08-13

Completion date

2025-11-13

Last updated

2025-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or metastatic solid tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Denmark, Germany, Poland, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026